Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy-Induced HBsAg Seroclearance. Lee HA, Lee HW, Seo YS, Sinn DH, et al. J Gastroenterol Hepatol 2025 Apr 24. doi: 10.1111/jgh.16973.

Read + Share

Amedeo Smart

Independent Medical Education

Lee HA, Lee HW, Seo YS, Sinn DH, et al. Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy-Induced HBsAg Seroclearance. J Gastroenterol Hepatol 2025 Apr 24. doi: 10.1111/jgh.16973.
PMID: 40273951